Phenotypes and New Treatments for Severe Asthma
نویسندگان
چکیده
1UGC Allergy, Hospital General de Málaga, Málaga, Spain 2Department of Allergy, Hospital Universitario Marqués de Valdecilla, Santander, Spain 3Allergy Section, Hospital Infantil Universitario Niño Jesús, Madrid, Spain 4Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain 5Department of Allergy, Hospital Universitario Dr. Peset, Valencia, Spain 6Department of Allergy, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain 7Department of Allergy, Complejo Hospitalario de Navarra, Pamplona, Spain 8UGC Allergy, Hospital Universitario Virgen Macarena, Sevilla, Spain
منابع مشابه
Airway Inflammatory Biomarker: Could It Tailor the Right Medications for the Right Asthmatic Patient?
Asthma is a heterogeneous disease, in which asthmatic patients present with different clinical phenotypes, variable endotypes, and different response to asthma medicines. Thus, we are faced with an asthma paradox; asthma is diagnosed subjectively by clinical history and treated with biologically active drugs. To solve this paradox, we need objective airway biomarkers to tailor the proper medica...
متن کاملThe Association between Obesity and Severityof Asthma in Children
Introduction: Asthma is the most common chronic airway disease in children, which is caused by genetic and environmental factors such as obesity. The aim of this study was to evaluate the relationship between obesity and asthma severity in children. Methods: This cross-sectional descriptive study included 200 asthmatic children aged 6 to 12 years in Yazd Shohadaye Kargar hospital in 2015 - 201...
متن کاملInnovative treatments for severe refractory asthma: how to choose the right option for the right patient?
The increasing understanding of the molecular biology and the etiopathogenetic mechanisms of asthma helps in identification of numerous phenotypes and endotypes, particularly for severe refractory asthma. For a decade, the only available biologic therapy that met the unmet needs of a specific group of patients with severe uncontrolled allergic asthma has been omalizumab. Recently, new biologic ...
متن کاملFuture biologic therapies in asthma.
Despite the administration of appropriate treatment, a high number of patients with asthma remain uncontrolled. This suggests the need for alternative treatments that are effective, safe and selective for the established asthma phenotypes, especially in patients with uncontrolled severe asthma. The most promising options among the new asthma treatments in development are biological therapies, p...
متن کاملNew therapies and management strategies in the treatment of asthma: patient-focused developments
It is increasingly recognized that large proportions of patients with asthma remain poorly controlled with daily symptoms, limitation in activities, or severe exacerbations despite traditional treatment with inhaled corticosteroids and other agents. This suggests that there is considerable scope for the refinement of traditional guidelines on the use of inhaled therapies in asthma and also a ne...
متن کاملFrom bedside to bench to clinic trials: identifying new treatments for severe asthma
Asthmatics with a severe form of the disease are frequently refractory to standard medications such as inhaled corticosteroids, underlining the need for new treatments to prevent the occurrence of potentially life-threatening episodes. A major obstacle in the development of new treatments for severe asthma is the heterogeneous pathogenesis of the disease, which involves multiple mechanisms and ...
متن کامل